Review



rhil-21  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher rhil-21
    Rhil 21, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhil-+21/rhil+21/pmc12060889-53-51-54
    Average 90 stars, based on 1 article reviews
    rhil-21 - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    Cell Differentiation:

    Article Title: Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib.
    Article Snippet: 5 × 105 B cells were suspended in RPMI containing 5% FCS, β-mercaptoethanol (MilliporeSigma), L-glutamin (Lonza), and apo-transferrin (MilliporeSigma); they were treated with and without evobrutinib (1 μM; EMD Serono, Billerica) in 48-well plates.

    Article Title: Human T-bet + B cell development is associated with BTK activity and suppressed by evobrutinib
    Article Snippet: In short, irradiated 3T3 fibroblasts expressing human CD40L were cocultured with purified naive mature (CD19 + CD38 –/dim CD27 – ; primary response) or memory (CD19 + CD38 –/dim CD27 + ; recall response) B cells in the presence of rhIL-21 (50 ng/ml; Thermo Fisher Scientific).

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In summary, 1000 FACS-sorted CXCR3 + or CXCR3 - memory (CD19 + CD38 –/dim CD27 + ) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19 + CD38 high CD27 high ) ASC outgrowth.

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5.
    Article Snippet: Individuals over the age of 65 comprise a substantial portion of the world population and become more susceptible to vaccine-preventable infections with age as vaccination response diminishes.. The underlying reason for this impaired vaccine response in older individuals is not entirely clear.. We evaluated potential differences in phenotypic and functional responses of B cells from healthy younger (22-45 years) and older (64-95 years) individuals that may associate with a diminished antibody response to influenza vaccination.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases
    Article Snippet: Briefly, irradiated NIH3T3 fibroblasts expressing human CD40L at density 1 × 10 6 /mL in 100 μL medium were co-cultured in 96 wells flat-bottom plates for 6 days with total CD19 + B cells or memory B cells at 0.5 × 10 5 /mL in 100 μL in the presence of rhIL-21 (50 ng/mL; ThermoFisher) and the presence or absence of amlexanox (10 or 5 μg/mL; LKT labs), IFN-alpha 2b (200 IU/mL; PBL Assay Science) and BAFF (125 ng/mL; Peprotech).

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5
    Article Snippet: Differentiation and proliferation culture PBMCs from the Red Cross cohort were thawed and incubated with CFSE (Life Technologies, Carlsbad, CA) for 10 min as per manufacturer’s instructions.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro : a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases.
    Article Snippet: For stimulations, Imiquimod (IQ) (1 μg/mL), CpG (1 μg/mL), PolyI:C (40 μg/mL), as well as G3- YsD (2.5 ng/ mL) and 3p- hpRNA (2.5 ng/mL) through LyoVec (all Invivogen) transfection were added, following manufacturer’s protocol.

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In vitromemory B-cell differentiation assays were performed as described earlier.1 In summary, 1000 FACS-sorted CXCR3+ or CXCR3- memory (CD19+CD38–/dimCD27+) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19+CD38high CD27high) ASC outgrowth.

    Irradiation:

    Article Title: Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib.
    Article Snippet: 5 × 105 B cells were suspended in RPMI containing 5% FCS, β-mercaptoethanol (MilliporeSigma), L-glutamin (Lonza), and apo-transferrin (MilliporeSigma); they were treated with and without evobrutinib (1 μM; EMD Serono, Billerica) in 48-well plates.

    Article Title: Human T-bet + B cell development is associated with BTK activity and suppressed by evobrutinib
    Article Snippet: In short, irradiated 3T3 fibroblasts expressing human CD40L were cocultured with purified naive mature (CD19 + CD38 –/dim CD27 – ; primary response) or memory (CD19 + CD38 –/dim CD27 + ; recall response) B cells in the presence of rhIL-21 (50 ng/ml; Thermo Fisher Scientific).

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In summary, 1000 FACS-sorted CXCR3 + or CXCR3 - memory (CD19 + CD38 –/dim CD27 + ) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19 + CD38 high CD27 high ) ASC outgrowth.

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5.
    Article Snippet: Individuals over the age of 65 comprise a substantial portion of the world population and become more susceptible to vaccine-preventable infections with age as vaccination response diminishes.. The underlying reason for this impaired vaccine response in older individuals is not entirely clear.. We evaluated potential differences in phenotypic and functional responses of B cells from healthy younger (22-45 years) and older (64-95 years) individuals that may associate with a diminished antibody response to influenza vaccination.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases
    Article Snippet: Briefly, irradiated NIH3T3 fibroblasts expressing human CD40L at density 1 × 10 6 /mL in 100 μL medium were co-cultured in 96 wells flat-bottom plates for 6 days with total CD19 + B cells or memory B cells at 0.5 × 10 5 /mL in 100 μL in the presence of rhIL-21 (50 ng/mL; ThermoFisher) and the presence or absence of amlexanox (10 or 5 μg/mL; LKT labs), IFN-alpha 2b (200 IU/mL; PBL Assay Science) and BAFF (125 ng/mL; Peprotech).

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5
    Article Snippet: Differentiation and proliferation culture PBMCs from the Red Cross cohort were thawed and incubated with CFSE (Life Technologies, Carlsbad, CA) for 10 min as per manufacturer’s instructions.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro : a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases.
    Article Snippet: For stimulations, Imiquimod (IQ) (1 μg/mL), CpG (1 μg/mL), PolyI:C (40 μg/mL), as well as G3- YsD (2.5 ng/ mL) and 3p- hpRNA (2.5 ng/mL) through LyoVec (all Invivogen) transfection were added, following manufacturer’s protocol.

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In vitromemory B-cell differentiation assays were performed as described earlier.1 In summary, 1000 FACS-sorted CXCR3+ or CXCR3- memory (CD19+CD38–/dimCD27+) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19+CD38high CD27high) ASC outgrowth.

    Expressing:

    Article Title: Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib.
    Article Snippet: 5 × 105 B cells were suspended in RPMI containing 5% FCS, β-mercaptoethanol (MilliporeSigma), L-glutamin (Lonza), and apo-transferrin (MilliporeSigma); they were treated with and without evobrutinib (1 μM; EMD Serono, Billerica) in 48-well plates.

    Article Title: Human T-bet + B cell development is associated with BTK activity and suppressed by evobrutinib
    Article Snippet: In short, irradiated 3T3 fibroblasts expressing human CD40L were cocultured with purified naive mature (CD19 + CD38 –/dim CD27 – ; primary response) or memory (CD19 + CD38 –/dim CD27 + ; recall response) B cells in the presence of rhIL-21 (50 ng/ml; Thermo Fisher Scientific).

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In summary, 1000 FACS-sorted CXCR3 + or CXCR3 - memory (CD19 + CD38 –/dim CD27 + ) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19 + CD38 high CD27 high ) ASC outgrowth.

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5.
    Article Snippet: Individuals over the age of 65 comprise a substantial portion of the world population and become more susceptible to vaccine-preventable infections with age as vaccination response diminishes.. The underlying reason for this impaired vaccine response in older individuals is not entirely clear.. We evaluated potential differences in phenotypic and functional responses of B cells from healthy younger (22-45 years) and older (64-95 years) individuals that may associate with a diminished antibody response to influenza vaccination.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases
    Article Snippet: Briefly, irradiated NIH3T3 fibroblasts expressing human CD40L at density 1 × 10 6 /mL in 100 μL medium were co-cultured in 96 wells flat-bottom plates for 6 days with total CD19 + B cells or memory B cells at 0.5 × 10 5 /mL in 100 μL in the presence of rhIL-21 (50 ng/mL; ThermoFisher) and the presence or absence of amlexanox (10 or 5 μg/mL; LKT labs), IFN-alpha 2b (200 IU/mL; PBL Assay Science) and BAFF (125 ng/mL; Peprotech).

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5
    Article Snippet: Differentiation and proliferation culture PBMCs from the Red Cross cohort were thawed and incubated with CFSE (Life Technologies, Carlsbad, CA) for 10 min as per manufacturer’s instructions.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro : a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases.
    Article Snippet: For stimulations, Imiquimod (IQ) (1 μg/mL), CpG (1 μg/mL), PolyI:C (40 μg/mL), as well as G3- YsD (2.5 ng/ mL) and 3p- hpRNA (2.5 ng/mL) through LyoVec (all Invivogen) transfection were added, following manufacturer’s protocol.

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In vitromemory B-cell differentiation assays were performed as described earlier.1 In summary, 1000 FACS-sorted CXCR3+ or CXCR3- memory (CD19+CD38–/dimCD27+) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19+CD38high CD27high) ASC outgrowth.

    Cell Culture:

    Article Title: Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib.
    Article Snippet: 5 × 105 B cells were suspended in RPMI containing 5% FCS, β-mercaptoethanol (MilliporeSigma), L-glutamin (Lonza), and apo-transferrin (MilliporeSigma); they were treated with and without evobrutinib (1 μM; EMD Serono, Billerica) in 48-well plates.

    Article Title: Human T-bet + B cell development is associated with BTK activity and suppressed by evobrutinib
    Article Snippet: In short, irradiated 3T3 fibroblasts expressing human CD40L were cocultured with purified naive mature (CD19 + CD38 –/dim CD27 – ; primary response) or memory (CD19 + CD38 –/dim CD27 + ; recall response) B cells in the presence of rhIL-21 (50 ng/ml; Thermo Fisher Scientific).

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In summary, 1000 FACS-sorted CXCR3 + or CXCR3 - memory (CD19 + CD38 –/dim CD27 + ) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19 + CD38 high CD27 high ) ASC outgrowth.

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5.
    Article Snippet: Individuals over the age of 65 comprise a substantial portion of the world population and become more susceptible to vaccine-preventable infections with age as vaccination response diminishes.. The underlying reason for this impaired vaccine response in older individuals is not entirely clear.. We evaluated potential differences in phenotypic and functional responses of B cells from healthy younger (22-45 years) and older (64-95 years) individuals that may associate with a diminished antibody response to influenza vaccination.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases
    Article Snippet: Briefly, irradiated NIH3T3 fibroblasts expressing human CD40L at density 1 × 10 6 /mL in 100 μL medium were co-cultured in 96 wells flat-bottom plates for 6 days with total CD19 + B cells or memory B cells at 0.5 × 10 5 /mL in 100 μL in the presence of rhIL-21 (50 ng/mL; ThermoFisher) and the presence or absence of amlexanox (10 or 5 μg/mL; LKT labs), IFN-alpha 2b (200 IU/mL; PBL Assay Science) and BAFF (125 ng/mL; Peprotech).

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5
    Article Snippet: Differentiation and proliferation culture PBMCs from the Red Cross cohort were thawed and incubated with CFSE (Life Technologies, Carlsbad, CA) for 10 min as per manufacturer’s instructions.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro : a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases.
    Article Snippet: For stimulations, Imiquimod (IQ) (1 μg/mL), CpG (1 μg/mL), PolyI:C (40 μg/mL), as well as G3- YsD (2.5 ng/ mL) and 3p- hpRNA (2.5 ng/mL) through LyoVec (all Invivogen) transfection were added, following manufacturer’s protocol.

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In vitromemory B-cell differentiation assays were performed as described earlier.1 In summary, 1000 FACS-sorted CXCR3+ or CXCR3- memory (CD19+CD38–/dimCD27+) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19+CD38high CD27high) ASC outgrowth.

    FACS:

    Article Title: Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib.
    Article Snippet: 5 × 105 B cells were suspended in RPMI containing 5% FCS, β-mercaptoethanol (MilliporeSigma), L-glutamin (Lonza), and apo-transferrin (MilliporeSigma); they were treated with and without evobrutinib (1 μM; EMD Serono, Billerica) in 48-well plates.

    Article Title: Human T-bet + B cell development is associated with BTK activity and suppressed by evobrutinib
    Article Snippet: In short, irradiated 3T3 fibroblasts expressing human CD40L were cocultured with purified naive mature (CD19 + CD38 –/dim CD27 – ; primary response) or memory (CD19 + CD38 –/dim CD27 + ; recall response) B cells in the presence of rhIL-21 (50 ng/ml; Thermo Fisher Scientific).

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In summary, 1000 FACS-sorted CXCR3 + or CXCR3 - memory (CD19 + CD38 –/dim CD27 + ) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19 + CD38 high CD27 high ) ASC outgrowth.

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5.
    Article Snippet: Individuals over the age of 65 comprise a substantial portion of the world population and become more susceptible to vaccine-preventable infections with age as vaccination response diminishes.. The underlying reason for this impaired vaccine response in older individuals is not entirely clear.. We evaluated potential differences in phenotypic and functional responses of B cells from healthy younger (22-45 years) and older (64-95 years) individuals that may associate with a diminished antibody response to influenza vaccination.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases
    Article Snippet: Briefly, irradiated NIH3T3 fibroblasts expressing human CD40L at density 1 × 10 6 /mL in 100 μL medium were co-cultured in 96 wells flat-bottom plates for 6 days with total CD19 + B cells or memory B cells at 0.5 × 10 5 /mL in 100 μL in the presence of rhIL-21 (50 ng/mL; ThermoFisher) and the presence or absence of amlexanox (10 or 5 μg/mL; LKT labs), IFN-alpha 2b (200 IU/mL; PBL Assay Science) and BAFF (125 ng/mL; Peprotech).

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5
    Article Snippet: Differentiation and proliferation culture PBMCs from the Red Cross cohort were thawed and incubated with CFSE (Life Technologies, Carlsbad, CA) for 10 min as per manufacturer’s instructions.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro : a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases.
    Article Snippet: For stimulations, Imiquimod (IQ) (1 μg/mL), CpG (1 μg/mL), PolyI:C (40 μg/mL), as well as G3- YsD (2.5 ng/ mL) and 3p- hpRNA (2.5 ng/mL) through LyoVec (all Invivogen) transfection were added, following manufacturer’s protocol.

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In vitromemory B-cell differentiation assays were performed as described earlier.1 In summary, 1000 FACS-sorted CXCR3+ or CXCR3- memory (CD19+CD38–/dimCD27+) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19+CD38high CD27high) ASC outgrowth.

    Purification:

    Article Title: Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib.
    Article Snippet: 5 × 105 B cells were suspended in RPMI containing 5% FCS, β-mercaptoethanol (MilliporeSigma), L-glutamin (Lonza), and apo-transferrin (MilliporeSigma); they were treated with and without evobrutinib (1 μM; EMD Serono, Billerica) in 48-well plates.

    Article Title: Human T-bet + B cell development is associated with BTK activity and suppressed by evobrutinib
    Article Snippet: In short, irradiated 3T3 fibroblasts expressing human CD40L were cocultured with purified naive mature (CD19 + CD38 –/dim CD27 – ; primary response) or memory (CD19 + CD38 –/dim CD27 + ; recall response) B cells in the presence of rhIL-21 (50 ng/ml; Thermo Fisher Scientific).

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In summary, 1000 FACS-sorted CXCR3 + or CXCR3 - memory (CD19 + CD38 –/dim CD27 + ) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19 + CD38 high CD27 high ) ASC outgrowth.

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5.
    Article Snippet: Individuals over the age of 65 comprise a substantial portion of the world population and become more susceptible to vaccine-preventable infections with age as vaccination response diminishes.. The underlying reason for this impaired vaccine response in older individuals is not entirely clear.. We evaluated potential differences in phenotypic and functional responses of B cells from healthy younger (22-45 years) and older (64-95 years) individuals that may associate with a diminished antibody response to influenza vaccination.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases
    Article Snippet: Briefly, irradiated NIH3T3 fibroblasts expressing human CD40L at density 1 × 10 6 /mL in 100 μL medium were co-cultured in 96 wells flat-bottom plates for 6 days with total CD19 + B cells or memory B cells at 0.5 × 10 5 /mL in 100 μL in the presence of rhIL-21 (50 ng/mL; ThermoFisher) and the presence or absence of amlexanox (10 or 5 μg/mL; LKT labs), IFN-alpha 2b (200 IU/mL; PBL Assay Science) and BAFF (125 ng/mL; Peprotech).

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5
    Article Snippet: Differentiation and proliferation culture PBMCs from the Red Cross cohort were thawed and incubated with CFSE (Life Technologies, Carlsbad, CA) for 10 min as per manufacturer’s instructions.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro : a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases.
    Article Snippet: For stimulations, Imiquimod (IQ) (1 μg/mL), CpG (1 μg/mL), PolyI:C (40 μg/mL), as well as G3- YsD (2.5 ng/ mL) and 3p- hpRNA (2.5 ng/mL) through LyoVec (all Invivogen) transfection were added, following manufacturer’s protocol.

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In vitromemory B-cell differentiation assays were performed as described earlier.1 In summary, 1000 FACS-sorted CXCR3+ or CXCR3- memory (CD19+CD38–/dimCD27+) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19+CD38high CD27high) ASC outgrowth.

    In Vitro:

    Article Title: Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib.
    Article Snippet: 5 × 105 B cells were suspended in RPMI containing 5% FCS, β-mercaptoethanol (MilliporeSigma), L-glutamin (Lonza), and apo-transferrin (MilliporeSigma); they were treated with and without evobrutinib (1 μM; EMD Serono, Billerica) in 48-well plates.

    Article Title: Human T-bet + B cell development is associated with BTK activity and suppressed by evobrutinib
    Article Snippet: In short, irradiated 3T3 fibroblasts expressing human CD40L were cocultured with purified naive mature (CD19 + CD38 –/dim CD27 – ; primary response) or memory (CD19 + CD38 –/dim CD27 + ; recall response) B cells in the presence of rhIL-21 (50 ng/ml; Thermo Fisher Scientific).

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In summary, 1000 FACS-sorted CXCR3 + or CXCR3 - memory (CD19 + CD38 –/dim CD27 + ) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19 + CD38 high CD27 high ) ASC outgrowth.

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5.
    Article Snippet: Individuals over the age of 65 comprise a substantial portion of the world population and become more susceptible to vaccine-preventable infections with age as vaccination response diminishes.. The underlying reason for this impaired vaccine response in older individuals is not entirely clear.. We evaluated potential differences in phenotypic and functional responses of B cells from healthy younger (22-45 years) and older (64-95 years) individuals that may associate with a diminished antibody response to influenza vaccination.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases
    Article Snippet: Briefly, irradiated NIH3T3 fibroblasts expressing human CD40L at density 1 × 10 6 /mL in 100 μL medium were co-cultured in 96 wells flat-bottom plates for 6 days with total CD19 + B cells or memory B cells at 0.5 × 10 5 /mL in 100 μL in the presence of rhIL-21 (50 ng/mL; ThermoFisher) and the presence or absence of amlexanox (10 or 5 μg/mL; LKT labs), IFN-alpha 2b (200 IU/mL; PBL Assay Science) and BAFF (125 ng/mL; Peprotech).

    Article Title: Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5
    Article Snippet: Differentiation and proliferation culture PBMCs from the Red Cross cohort were thawed and incubated with CFSE (Life Technologies, Carlsbad, CA) for 10 min as per manufacturer’s instructions.

    Article Title: Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro : a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases.
    Article Snippet: For stimulations, Imiquimod (IQ) (1 μg/mL), CpG (1 μg/mL), PolyI:C (40 μg/mL), as well as G3- YsD (2.5 ng/ mL) and 3p- hpRNA (2.5 ng/mL) through LyoVec (all Invivogen) transfection were added, following manufacturer’s protocol.

    Article Title: Twin study dissects CXCR3 + memory B cells as non-heritable feature in multiple sclerosis
    Article Snippet: In vitromemory B-cell differentiation assays were performed as described earlier.1 In summary, 1000 FACS-sorted CXCR3+ or CXCR3- memory (CD19+CD38–/dimCD27+) B cells were cultured on irradiated 3T3 fibroblasts expressing human CD40L in the presence of rhIL-21 (50 ng/mL; Thermo Fisher Scientific) to trigger (CD19+CD38high CD27high) ASC outgrowth.



    Similar Products

    94
    R&D Systems rhil 21
    Rhil 21, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhil-+21/Recombinant+Human+IL-21+Protein/pmc13089343-228-29-32
    Average 94 stars, based on 1 article reviews
    rhil 21 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    R&D Systems rhil 21 r d systems 8879 il cf
    Rhil 21 R D Systems 8879 Il Cf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhil-+21/Recombinant+Human+IL-21+Protein%2C+CF/us12378526-348-174-175
    Average 93 stars, based on 1 article reviews
    rhil 21 r d systems 8879 il cf - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher rhil- 21
    Rhil 21, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhil-+21/rhil+21/pm40341181-65-58-62
    Average 90 stars, based on 1 article reviews
    rhil- 21 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher rhil-21
    Rhil 21, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhil-+21/rhil+21/pmc12060889-53-51-54
    Average 90 stars, based on 1 article reviews
    rhil-21 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Sartorius AG rhil-21
    Rhil 21, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhil-+21/rhil+21/pm39630887-350-47-51
    Average 90 stars, based on 1 article reviews
    rhil-21 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    ImmunoTools rhil-21
    Rhil 21, supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhil-+21/rhil+21/pm39393568-234-70-73
    Average 90 stars, based on 1 article reviews
    rhil-21 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    PeproTech rhil-21
    Rhil 21, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhil-+21/rhil+21/pmc11556684-94-39-42
    Average 90 stars, based on 1 article reviews
    rhil-21 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    R&D Systems rhil-21
    Rhil 21, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhil-+21/rhil+21/pmc11311295-53-27-30
    Average 90 stars, based on 1 article reviews
    rhil-21 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results